E-LIB Suche - Ergebnisse für: Goker-Alpan, O.

1

P372 Safety of home administration of cipaglucosidase alfa ..:

Byrne, B. ; Diaz-Manera, J. ; Goker-Alpan, O....
Neuromuscular Disorders. 33 (2023) - p. S151 , 2023

Link: https://doi.org/10.1016/..

2

FP.17 Long-term follow-up of cipaglucosidase alfa/miglustat..:

Schoser, B. ; Kishnani, P. ; Bratkovic, D....
Neuromuscular Disorders. 32 (2022) - p. S73 , 2022

Link: https://doi.org/10.1016/..

3

P.025 Efficacy and safety results of the avalglucosidase al..:

Tarnopolsky, M ; Attarian, S ; Borges, J...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48 (2021) s3 - p. S27-S27 , 2021

Link: https://doi.org/10.1017/..

4

AUTOPHAGIC MYOPATHIES / MYOFIBRILLAR MYOPATHIES / DISTAL MY..:

Schoser, B. ; Barohn, R. ; Byrne, B....
Neuromuscular Disorders. 30 (2020) - p. S49 , 2020

Link: https://doi.org/10.1016/..

5

PRECLINICAL APPROACHES AND EARLY CLINICAL RESULTS:

Schoser, B. ; Kishnani, P. ; Bratkovic, D....
Neuromuscular Disorders. 29 (2019) - p. S122 , 2019

Link: https://doi.org/10.1016/..

6

P.69NEO1 and NEO-EXT studies: exploratory efficacy of repea..:

Schoser, B. ; Barohn, R. ; Byrne, B....
Neuromuscular Disorders. 29 (2019) - p. S60-S61 , 2019

Link: https://doi.org/10.1016/..

7

NEW THERAPEUTIC APPROACHES AND THEIR READOUT:

Schoser, B. ; Bratkovic, D. ; Byrne, B....
Neuromuscular Disorders. 28 (2018) - p. S92 , 2018

Link: https://doi.org/10.1016/..

8

T.P.24:

Thurberg, B.L. ; van der Ploeg, A. ; Kissel, J.T....
Neuromuscular Disorders. 24 (2014) 9-10 - p. 871-872 , 2014

Link: https://doi.org/10.1016/..

9

T.P.45 An ongoing phase 2a study to investigate drug–drug i..:

Kishnani, P. ; Tarnopolsky, M. ; Sivakumar, K....
Neuromuscular Disorders. 22 (2012) 9-10 - p. 852 , 2012

Link: https://doi.org/10.1016/..

10

T.P.46 A novel phase 2a study design to investigate drug-dr..:

Kishnani, P. ; Tarnopolsky, M. ; Sivakumar, K....
Neuromuscular Disorders. 22 (2012) 9-10 - p. 852 , 2012

Link: https://doi.org/10.1016/..

11

P3.038 GBA mutations and clinical features of patients eval..:

Lopez, G. ; Hyuk Choi, J. ; Gupta, N....
Parkinsonism & Related Disorders. 15 (2009) - p. S157-S158 , 2009

Link: https://doi.org/10.1016/..

12

UNIPARENTAL DISOMY OF CHROMOSOME 1 CAUSING CONCURRENT CHARC..:

Benko, W. S. ; Hruska, K. S. ; Nagan, N....
Neurology. 70 (2008) 12 - p. 976-978 , 2008

Link: https://doi.org/10.1212/..

13

Glucocerebrosidase mutations are an important risk factor f..:

Goker-Alpan, O. ; Giasson, B. I. ; Eblan, M. J....
Neurology. 67 (2006) 5 - p. 908-910 , 2006

Link: https://doi.org/10.1212/..

14

Reply to Mistry et al. The Two Substrate Reduction Therapie..:

Hughes, DA ; Deegan, P ; Giraldo, P...
https://discovery.ucl.ac.uk/id/eprint/10173849/1/jcm-12-04017.pdf. , 2023

Link: https://discovery.ucl.ac..

15

Long-term safety and efficacy of pegunigalsidase alfa: A mu..:

Hughes, D ; Gonzalez, D ; Maegawa, G...
https://discovery.ucl.ac.uk/id/eprint/10181024/1/1-s2.0-S109836002300984X-main.pdf. , 2023

Link: https://discovery.ucl.ac..